Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling
1 other identifier
observational
482
1 country
1
Brief Summary
Medication errors are common in intensive care (Valentin A et al., BMJ. 2009;338). Standardized color coded labels for user applied syringes enjoy strong support from many health professionals, thinking that this might increase patient safety. Whether this is true or not warrants further research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2010
CompletedStudy Start
First participant enrolled
November 1, 2010
CompletedFirst Posted
Study publicly available on registry
November 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedNovember 2, 2015
October 1, 2015
7 months
November 1, 2010
October 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary objective is to assess if standardized drug syringe labelling is used in European ICUs.
Online survey for ICU physicians (members of the ESICM).
A period of 90 days.
Secondary Outcomes (1)
The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry.
A period of 90 days
Study Arms (1)
Data collection group: ICU physicians
Online survey for ICU physicians (members of the European Society of Intensive Care Medicine (ESICM)).
Eligibility Criteria
Members of the European Society of Intensive Care Medicine (ESICM)
You may qualify if:
- Members of the European Society of Intensive Care Medicine (ESICM)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Intensive Care Medicine Campus Virchow Klinikum/Campus Charité Mitte
Berlin, State of Berlin, 13353/10117, Germany
Related Publications (2)
Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B, Bauer P, Metnitz P; Research Group on Quality Improvement of the European Society of Intensive Care Medicine (ESICM); Sentinel Events Evaluation (SEE) Study Investigators. Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ. 2009 Mar 12;338:b814. doi: 10.1136/bmj.b814.
PMID: 19282436BACKGROUNDBalzer F, Wickboldt N, Spies C, Walder B, Goncerut J, Citerio G, Rhodes A, Kastrup M, Boemke W. Standardised drug labelling in intensive care: results of an international survey among ESICM members. Intensive Care Med. 2012 Aug;38(8):1298-305. doi: 10.1007/s00134-012-2569-1. Epub 2012 Apr 20.
PMID: 22527084DERIVED
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite University, Berlin
Study Record Dates
First Submitted
November 1, 2010
First Posted
November 2, 2010
Study Start
November 1, 2010
Primary Completion
June 1, 2011
Study Completion
September 1, 2011
Last Updated
November 2, 2015
Record last verified: 2015-10